| Literature DB >> 24196355 |
Youssuf A Gherbawy1, Ismail M Shalaby, Mahmoud Syed Abd El-Sadek, Hesham M Elhariry, Banaja A Abdelilah.
Abstract
Recently, new strains of Fasciola demonstrated drug resistance, which increased the need for new drugs or improvement of the present drugs. Nanotechnology is expected to open some new opportunities to fight and prevent diseases using an atomic scale tailoring of materials. The ability to uncover the structure and function of biosystems at the nanoscale, stimulates research leading to improvement in biology, biotechnology, medicine and healthcare. The size of nanomaterials is similar to that of most biological molecules and structures; therefore, nanomaterials can be useful for both in vivo and in vitro biomedical research and applications. Therefore, this work aimed to isolate fungal strains from Taif soil samples, which have the ability to synthesize silver nanoparticles. The fungus Trichoderma harzianum, when challenged with silver nitrate solution, accumulated silver nanoparticles (AgNBs) on the surface of its cell wall in 72 h. These nanoparticles, dislodged by ultrasonication, showed an absorption peak at 420 nm in a UV-visible spectrum, corresponding to the plasmon resonance of silver nanoparticles. The transmission electron micrographs of dislodged nanoparticles in aqueous solution showed the production of reasonably monodisperse silver nanoparticles (average particle size: 4.66 nm) by the fungus. The percentage of non hatching eggs treated with the Triclabendazole drug was 69.67%, while this percentage increased to 89.67% in combination with drug and AgNPs.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24196355 PMCID: PMC3856041 DOI: 10.3390/ijms141121887
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1HRTEM image and size dispersion histogram of Ag nanoparticles.
Figure 2UV-visible spectra of fungal filtrate containing Ag nanoparticles.
A comparison between hatched and non-hatched Fasciola eggs in both treatments (Drug alone) and (drug with AgNPs). As between both treatments the data is almost the same (p value is <0.001).
| Number of eggs | Non-treated eggs | Eggs | Eggs | |||
|---|---|---|---|---|---|---|
|
| ||||||
| hatched | non-hatched | hatched | non-hatched | hatched | non-hatched | |
| 100 | 100 | 0 | 30 | 70 | 10 | 90 |
| 100 | 100 | 0 | 25 | 75 | 5 | 95 |
| 100 | 100 | 0 | 32 | 68 | 8 | 92 |
| 100 | 100 | 0 | 28 | 72 | 11 | 89 |
| 100 | 100 | 0 | 35 | 65 | 15 | 85 |
| 100 | 100 | 0 | 32 | 68 | 13 | 87 |
| Mean | 100 | 0 | 30.33 | 69.67 | 10.33 | 89.67 |
| SD | 0 | 0 | 3.50 | 3.50 | 3.56 | 3.56 |
| 0 | 0 | 96.26 | 96.26 | |||
| Significance | 0 | 0 | <0.001 | <0.001 | ||
| Percentage | 100% | 0% | 30.33% | 69.67% | 10.33% | 89.67% |
Figure 3Fasciola egg (control, non treated) Notice the smooth texture of the egg surface.
Figure 4Fasciola egg treated in vitro with the drug only. Notice the alterations on the egg surface due to drug administration.
Figure 5Fasciola egg treated in vitro with the drug with nano silver particles. Notice the perforations on the egg surface due to the effect of drug carried on nano silver particles.